Mumbai lab develops home sperm-test kit
- Mann ki Baat live updates: PM Modi to address the nation
- To check donations in cash to parties, EC seeks Rs 20 crore cap
- MoP on appointments: Government gets one ok, Supreme Court agrees to age criterion for HC judges
- Gujarat student clash turns communal, one dead
- From chicken shops to snack sellers, I-T knock on Surat doors
In what is considered a breakthrough in fertility treatment, scientists at Mumbai's National Institute of Research in Reproductive Health (NIRRH) have patented a sperm-quality test that is simple enough to be developed into a home kit.
The Indian Council of Medical Research (ICMR) has invited bids from private companies to produce it commercially.
The Resazurin Reduction Test (RRT) is more effective in assessing male fertility than the standard semen analysis which cannot evaluate functional competence of sperms. RRT also seeks to replace four advanced and very expensive diagnostic tools that assess sperm count, motility and quality. RRT, its developers hope, can be sold for Rs 100 per kit.
RRT is a dye test involving a coloured compound containing a sodium salt that functions as an oxidation reduction indicator. It is readily reduced — a specific chemical reaction involving transfer of electrons — by motile sperm. The reduction happens faster if the number of such sperms is high. Information from this single test is equal to the data from four advanced tests that take a week and cost about Rs 20,000. Also, these tests are not routinely done in any centre in India.
- Agricultural growth in Uttar Pradesh can be achieved by putting dairy in the lead role
- Past efforts at out-of-court resolution of Ayodhya dispute have been non-starters
- New NITI Aayog recruitment rules should trigger a revamp of the Indian state’s human capital
- Adityanath’s long opposition to the ‘red revolution’ has many takers in Nepal
- Rural India is woefully under-informed of how it can both transform sanitation and earn money
- Celebrating gods, neglecting children